Atripla Interactions
There are 973 drugs known to interact with Atripla (efavirenz/emtricitabine/tenofovir disoproxil), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 391 are major, 563 are moderate, and 19 are minor.
- View all 973 medications that may interact with Atripla
- View Atripla alcohol/food interactions (2)
- View Atripla disease interactions (11)
Most frequently checked interactions
View interaction reports for Atripla (efavirenz / emtricitabine / tenofovir disoproxil) and the medicines listed below.
- acyclovir
- amlodipine
- aspirin
- atorvastatin
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- bupropion
- citalopram
- clonazepam
- Crestor (rosuvastatin)
- cyclobenzaprine
- Cymbalta (duloxetine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydrochlorothiazide
- hydroxyzine
- ibuprofen
- Lipitor (atorvastatin)
- lisinopril
- Lyrica (pregabalin)
- metformin
- multivitamin
- omeprazole
- pravastatin
- trazodone
- Truvada (emtricitabine / tenofovir disoproxil)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- zolpidem
Atripla alcohol/food interactions
There are 2 alcohol/food interactions with Atripla (efavirenz / emtricitabine / tenofovir disoproxil).
Atripla disease interactions
There are 11 disease interactions with Atripla (efavirenz / emtricitabine / tenofovir disoproxil) which include:
- hepatitis B
- hepatotoxicity
- liver disease
- mental symptoms
- QT prolongation
- seizures
- hemodialysis
- renal dysfunction
- bone toxicity
- liver disease
- renal dysfunction
Report options
More about Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Atripla consumer information
- Compare alternatives
- Reviews (105)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Dovato
Dovato is a complete HIV-1 treatment regimen in one tablet that may be used in adults and children ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Zidovudine
Zidovudine systemic is used for HIV Infection, nonoccupational exposure, occupational exposure ...
Emtricitabine/tenofovir disoproxil
Emtricitabine/tenofovir disoproxil (brand name Truvada) is a combination antiviral tablet that may ...
Emtricitabine
Emtricitabine systemic is used for HIV Infection, nonoccupational exposure, occupational exposure
Tenofovir disoproxil
Tenofovir disoproxil systemic is used for hepatitis b, HIV Infection, nonoccupational exposure ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
